Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain

BACKGROUND: Sublingual (s.l.) administration of soluble protein antigens, inactivated viruses, or virus-like particles has been shown to induce broad immune responses in mucosal and extra-mucosal tissues. Recombinant replication-defective adenovirus vectors (rADVs) infect mucosa surface and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Byoung-Shik, Stadler, Konrad, Nguyen, Huan Huu, Yun, Cheol-Heui, Kim, Dong Wook, Chang, Jun, Czerkinsky, Cecil, Song, Man Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489719/
https://www.ncbi.nlm.nih.gov/pubmed/22995185
http://dx.doi.org/10.1186/1743-422X-9-215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489719/
https://www.ncbi.nlm.nih.gov/pubmed/22995185
http://dx.doi.org/10.1186/1743-422X-9-215

Ejemplares similares